Skip to main content
All lobbying clients

ACURX PHARMACEUTICALS, INC.

Lobbying client · New York · filed 2025 to 2026

biopharmaceutical company

$200,000 Reported spend
7 Filings counted
1 Outside firm hired
7 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (63561), filed by the registrant listed below.

 Who filed for this client 1

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 7
  • H.R. 4026
    POST Act of 2025
    3 filings
  • S. 2296
    National Defense Authorization Act for Fiscal Year 2026
    3 filings
  • H.R. 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…
    2 filings
  • H.R. 5304
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
    2 filings
  • H.R. 9260
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
    2 filings
  • S. 2572
    Department of Defense Appropriations Act, 2026
    2 filings
  • S. 2587
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
    2 filings
 Reported by year 2 years
  • 2026 $90,000 3 filings
  • 2025 $110,000 4 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 4
  • HOUSE OF REPRESENTATIVES 7
  • SENATE 7
  • Navy, Dept of 2
  • Defense Threat Reduction Agency (DTRA) 1
 Recent filings 7 total
Q3 report
INNOVATIVE FEDERAL STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 20, 2026
View → Q2 report
INNOVATIVE FEDERAL STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 20, 2026
View → Q1 report
INNOVATIVE FEDERAL STRATEGIES, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 20, 2026
View → Q4 report
INNOVATIVE FEDERAL STRATEGIES, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $30,000 income · posted Jan 20, 2026
View → Q3 report
INNOVATIVE FEDERAL STRATEGIES, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 20, 2025
View → Q2 report
INNOVATIVE FEDERAL STRATEGIES, LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 18, 2025
View → Q1 report
INNOVATIVE FEDERAL STRATEGIES, LLC
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Apr 16, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem